Woodmont Investment Counsel’s Apollo Endosurgery, Inc. APEN Stock Holding History

Woodmont Investment Counsel’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-20,000	Closed	-$69K	–	190
2018 Q4	$69K	Sell	20,000 -3,115	-13%	-$15.4K	0.02%	175
2018 Q3	$166K	Hold	23,115	–	–	0.05%	157
2018 Q2	$161K	Buy	23,115 +1,000	+5%	+$6.22K	0.04%	163
2018 Q1	$139K	Buy	22,115 +2,115	+11%	+$13.3K	0.04%	168
2017 Q4	$112K	Sell	20,000 -27,000	-57%	-$123K	0.03%	186
2017 Q3	$220K	Buy	+47,000	New	+$248K	0.06%	177

Other funds holding APEN

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return

Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NSEDCP

NJ State Employees Deferred Compensation Plan Trenton, New Jersey $906M AUM 24.85% 1-Year Est. Return

Woodmont Investment Counsel's APEN Position: Q1 2019 in Review

Woodmont Investment Counsel sold out of Apollo Endosurgery, Inc. (APEN) in Q1 2019, closing a stake of 20,000 shares — an estimated $69K sold.

Woodmont Investment Counsel first reported a position in APEN in Q3 2017 and held it in 6 quarters. The position peaked at $220K in Q3 2017. 31 funds tracked by Wall St. Rank hold APEN as of Q1 2019.

Woodmont Investment Counsel reported no remaining Apollo Endosurgery, Inc. position as of Q1 2019 after selling out during the quarter.
Woodmont Investment Counsel sold 20,000 Apollo Endosurgery, Inc. shares in Q1 2019, an estimated $69K.
Woodmont Investment Counsel first reported a position in Apollo Endosurgery, Inc. in Q3 2017 and held it in 6 quarters.
Woodmont Investment Counsel's Apollo Endosurgery, Inc. position peaked at $220K in Q3 2017.
31 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q1 2019.

Based on Woodmont Investment Counsel's 13F filing for Q1 2019, filed 15 May 2019.